Profile data is unavailable for this security.
About the company
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
- Revenue in USD (TTM)88.83m
- Net income in USD-13.99m
- Incorporated1998
- Employees159.00
- LocationBioLife Solutions IncSUITE 310, 3303 MONTE VILLA PARKWAYBOTHELL 98021United StatesUSA
- Phone+1 (425) 401-1400
- Fax+1 (425) 402-1433
- Websitehttps://www.biolifesolutions.com/
More ▼
Mergers & acquisitions
| Acquired company | BLFS:NAQ since announced | Transaction value |
|---|---|---|
| PanTHERA CryoSolutions Inc | 8.48% | 12.84m |
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SI-Bone Inc | 193.58m | -21.76m | 667.79m | 349.00 | -- | 3.87 | -- | 3.45 | -0.5113 | -0.5113 | 4.55 | 3.98 | 0.8393 | 1.29 | 7.53 | 554,664.80 | -9.43 | -24.17 | -10.61 | -26.87 | 79.62 | 82.72 | -11.24 | -40.93 | 6.62 | -- | 0.1711 | -- | 20.37 | 19.96 | 28.67 | -- | 33.83 | -- |
| Bioventus Inc | 563.83m | 7.82m | 705.14m | 950.00 | 75.85 | 4.25 | 12.29 | 1.25 | 0.1123 | 0.1123 | 8.39 | 2.01 | 0.7666 | 1.95 | 4.47 | 606,267.80 | 1.31 | -6.29 | 1.89 | -8.49 | 67.76 | 67.40 | 1.71 | -12.07 | 1.14 | 1.73 | 0.616 | -- | 11.89 | 11.00 | 65.33 | -- | -15.55 | -- |
| CeriBell Inc | 82.81m | -52.46m | 775.30m | 281.00 | -- | 4.72 | -- | 9.36 | -1.45 | -1.45 | 2.29 | 4.43 | 0.6717 | 1.54 | 6.36 | 294,708.20 | -42.55 | -- | -48.06 | -- | 87.99 | -- | -63.35 | -- | 12.25 | -29.42 | 0.1074 | -- | 44.71 | -- | -37.30 | -- | -- | -- |
| Butterfly Network Inc | 88.45m | -79.87m | 841.17m | 190.00 | -- | 4.13 | -- | 9.51 | -0.3347 | -0.3347 | 0.3729 | 0.8071 | 0.3186 | 0.7409 | 3.93 | 465,515.80 | -28.77 | -- | -34.57 | -- | 43.24 | -- | -90.31 | -190.03 | 3.56 | -- | 0.00 | -- | 24.52 | -- | 45.78 | -- | -- | -- |
| Integra Lifesciences Holdings Corp | 1.64bn | -495.34m | 851.36m | 4.40k | -- | 0.8199 | -- | 0.5182 | -6.46 | -6.46 | 21.45 | 13.33 | 0.4261 | 1.52 | 6.34 | 373,741.10 | -12.85 | 2.90 | -15.39 | 3.25 | 57.21 | 62.59 | -30.15 | 7.14 | 1.80 | 2.68 | 0.6383 | 0.00 | 4.47 | 1.20 | -110.25 | -- | -3.19 | -- |
| STAAR Surgical Co | 230.59m | -96.37m | 866.01m | 1.16k | -- | 2.43 | -- | 3.76 | -1.96 | -1.96 | 4.64 | 7.17 | 0.464 | 1.29 | 2.80 | 199,300.80 | -19.39 | 3.81 | -22.26 | 4.42 | 73.87 | 77.03 | -41.79 | 5.42 | 4.35 | -- | 0.00 | 0.00 | -2.64 | 15.89 | -194.66 | -- | 18.11 | -- |
| Castle Biosciences Inc | 343.53m | -12.24m | 940.75m | 761.00 | -- | 2.01 | 30.82 | 2.74 | -0.4533 | -0.4533 | 11.67 | 16.02 | 0.6377 | 9.05 | 6.89 | 451,419.20 | -2.27 | -6.95 | -2.50 | -7.52 | 79.94 | 80.76 | -3.56 | -17.49 | 6.31 | -- | 0.0218 | -- | 51.09 | 44.97 | 131.75 | 43.57 | 97.74 | -- |
| Inmode Ltd | 364.49m | 149.58m | 955.72m | 599.00 | 7.02 | 1.46 | 6.36 | 2.62 | 2.15 | 2.15 | 5.39 | 10.34 | 0.4677 | 1.19 | 9.24 | 608,504.20 | 19.19 | 28.05 | 21.15 | 31.28 | 78.82 | 83.39 | 41.04 | 40.99 | 8.71 | -- | 0.00 | 0.00 | -19.76 | 20.35 | -8.41 | 24.28 | -0.7024 | -- |
| BioLife Solutions Inc | 88.83m | -13.99m | 1.09bn | 159.00 | -- | 3.07 | -- | 12.27 | -0.2922 | -0.061 | 1.87 | 7.37 | 0.2296 | 0.8875 | 6.18 | 558,698.10 | -3.62 | -1.92 | -3.92 | -2.10 | 70.02 | 52.54 | -15.75 | -9.06 | 3.64 | -- | 0.0207 | -- | 8.44 | 24.62 | 38.27 | -- | 19.15 | -- |
| Novocure Ltd | 642.27m | -177.65m | 1.12bn | 1.49k | -- | 3.29 | -- | 1.75 | -1.61 | -1.61 | 5.81 | 3.05 | 0.4973 | 4.01 | 8.43 | 431,632.40 | -13.75 | -9.61 | -33.14 | -11.84 | 75.57 | 77.57 | -27.66 | -19.32 | 1.50 | -- | 0.6887 | -- | 18.82 | 11.49 | 18.55 | -- | 32.52 | -- |
| Iradimed Corp | 80.51m | 21.18m | 1.22bn | 160.00 | 58.18 | 12.41 | 55.08 | 15.16 | 1.65 | 1.65 | 6.27 | 7.73 | 0.7706 | 1.61 | 6.65 | 503,195.40 | 20.28 | 14.28 | 22.52 | 15.97 | 77.07 | 76.58 | 26.31 | 22.27 | 5.72 | -- | 0.00 | 66.71 | 11.71 | 13.72 | 11.87 | 14.84 | 78.55 | -- |
| Enovis Corp | 2.23bn | -1.37bn | 1.28bn | 7.37k | -- | 0.6328 | -- | 0.5726 | -24.20 | -24.20 | 39.35 | 35.33 | 0.4474 | 1.56 | 5.37 | 303,144.60 | -27.38 | -3.14 | -30.81 | -3.56 | 57.19 | 52.01 | -61.19 | -9.77 | 1.16 | 0.0495 | 0.4018 | -- | 23.46 | -8.73 | -1,423.10 | -- | 7.58 | -- |
| Tandem Diabetes Care Inc | 1.01bn | -203.37m | 1.28bn | 2.65k | -- | 9.63 | -- | 1.27 | -3.05 | -3.05 | 15.08 | 1.96 | 1.10 | 3.25 | 8.64 | 380,000.40 | -22.20 | -10.11 | -30.80 | -12.33 | 53.23 | 51.67 | -20.20 | -11.71 | 1.90 | -9.88 | 0.7028 | -- | 25.74 | 21.01 | 56.86 | -- | 27.42 | -- |
| Conmed Corp | 1.37bn | 47.06m | 1.29bn | 3.90k | 27.50 | -- | 10.64 | 0.9387 | 1.52 | 1.52 | 44.24 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 54.08 | 55.56 | 3.42 | 3.78 | -- | 3.24 | -- | -- | 5.18 | 9.77 | -64.47 | 37.66 | -- | -5.59 |
| Adapthealth Corp | 3.26bn | 75.81m | 1.45bn | 10.50k | 19.30 | 0.8979 | 3.05 | 0.446 | 0.5553 | 0.5553 | 23.90 | 11.94 | 0.7354 | 17.20 | 8.33 | 310,020.30 | 1.96 | -2.81 | 2.28 | -3.17 | 25.32 | 19.63 | 2.67 | -4.19 | 0.8584 | 2.30 | 0.5253 | -- | 1.90 | 43.84 | 112.19 | -- | 70.36 | -- |
Data as of Feb 10 2026. Currency figures normalised to BioLife Solutions Inc's reporting currency: US Dollar USD
58.53%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Casdin Capital LLCas of 15 Oct 2025 | 5.96m | 12.44% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 5.18m | 10.82% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 5.10m | 10.65% |
| Invesco Advisers, Inc.as of 30 Sep 2025 | 3.45m | 7.20% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 2.77m | 5.77% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 1.46m | 3.04% |
| Fred Alger Management LLCas of 30 Sep 2025 | 1.11m | 2.32% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 1.02m | 2.12% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 1.00m | 2.10% |
| Columbia Wanger Asset Management LLCas of 30 Jun 2025 | 997.60k | 2.08% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
